A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Explore the booming Chromosomal Microarray Market, projected to grow from USD 1.69 Billion in 2025 to USD 3.32 Billion by 2034, at a 10.2% CAGR. Driven by demand for advanced genetic diagnostics ...

A genetic test known as chromosomal microarray analysis (CMA) can help identify the cause of sudden infant death syndrome (SIDS) and sudden unexplained death in childhood (SUDC), finds a study led ...

Advancements in chromosomal microarrays (CMAs) have greatly expanded the capabilities of cytogenetics testing in recent years, including the ability to yield insights into genetic risk factors and ...

Chromosomal microarray analysis (CMA) becomes a proven method and is implemented to detect gains and losses of DNA and absence of heterozygosity across the genome. Next-generation sequencing ...

Chromosomal Microarray Analysis (CMA), a comprehensive prenatal genetic test for patients undergoing an amniocentesis or chorionic villus sampling (CVS) Diagnostic workup for the cause of fetal birth ...

The findings suggest that chromosomal microarray analysis (CMA), the method that the researchers used in the study, "should be considered in the genetic evaluation of SUDC," Brownstein said.

New Type Of Genetic Testing May Help Improve Autism Diagnosis Scientists at the Memorial University of Newfoundland in Canada have developed a pair of comprehensive genetic tests that could help ...

Chromosomal microarray analysis (CMA) is a high-resolution technique that allows for the detection of copy number variations (CNVs) across the genome, offering significantly higher sensitivity than ...